Antiviral activity of Humulus lupulus (HOP) aqueous extract against MERS-CoV and SARS-CoV-2: in-vitro and in-silico study

References

• Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020;144(7):799–805.
   PubMed Web of Science ®Google Scholar
• de Groot RJ, Baker SC, Baric RS, et al. Middle east respiratory syndrome coronavirus (MERS-CoV): announcement of the coronavirus study group. J Virol. 2013;87(14):7790–7792.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Disease Outbreak News; Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia. 2022. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON422.
   Google Scholar
• KDCA. Middle East Respiratory Syndrome (MERS). Policy & Services 2018. 2018. Available from: https://www.kdca.go.kr/contents.es?mid=a30329000000.
   Google Scholar
• Diamond MS, Kanneganti T-D. Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol. 2022;23(2):165–176.
   PubMed Web of Science ®Google Scholar
• Banik G, Khandaker G, Rashid H. Middle east respiratory syndrome coronavirus “MERS-CoV”: current knowledge gaps. Paediatr Respir Rev. 2015;16(3):197–202.
   PubMed Web of Science ®Google Scholar
• Jansen J, Reimer KC, Nagai JS, COVID Moonshot consortium, et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell. 2022;29(2):217–231.e8.
   PubMed Web of Science ®Google Scholar
• Song E, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. bioRxiv. 2020.
   Google Scholar
• Gavriatopoulou M, Korompoki E, Fotiou D, et al. Organ-specific manifestations of COVID-19 infection. Clin Exp Med. 2020;20(4):493–506.
   PubMed Web of Science ®Google Scholar
• Stevens P. Angiosperm phylogeny website. 2001. Available at: http://www.mobot.org/MOBOT/research/APweb
   Google Scholar
• Di Sotto A, Checconi P, Celestino I, et al. Antiviral and antioxidant activity of a hydroalcoholic extract from Humulus lupulus. Oxid Med Cell Longev. 2018;2018:5919237.
   PubMed Web of Science ®Google Scholar
• Abiko Y, Paudel D, Uehara O. HOPs components and oral health. J Funct Foods. 2022;92:105035.
   Web of Science ®Google Scholar
• Blaxland J, Thomas R, Baillie L. The antibacterial effect of Humulus lupulus (HOPs) against Mycobacterium bovis BCG: a promising alternative in the fight against bovine tuberculosis? Beverages. 2022;8(3):43.
   Web of Science ®Google Scholar
• Di Lodovico S, Menghini L, Ferrante C, et al. Hop extract: an efficacious antimicrobial and anti-biofilm agent against multidrug-resistant Staphylococci strains and Cutibacterium acnes. Front Microbiol. 2020;11:1852.
   PubMed Web of Science ®Google Scholar
• Bocquet L, Rivière C, Neut C, et al. Antimicrobial properties of phenolic compounds from hops, Humulus lupulus L.: fight against multidrug resistance. Planta Med. 2016;81(S 01):S1–S381.
   Google Scholar
• Bocquet L, Sahpaz S, Bonneau N, et al. Phenolic compounds from Humulus lupulus as natural antimicrobial products: new weapons in the fight against methicillin resistant Staphylococcus aureus, Leishmania mexicana and Trypanosoma brucei strains. Molecules. 2019;24(6):1024.
   PubMed Web of Science ®Google Scholar
• Seyedpour S, Khodaei B, Loghman AH, et al. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: a systematic review of in vitro and in vivo studies. J Cell Physiol. 2021;236(4):2364–2392.
   PubMed Web of Science ®Google Scholar
• Perera RA, Wang P, Gomaa MR, et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013;18(36):pii = 20574.
   PubMedGoogle Scholar
• Kandeil A, Mostafa A, El-Shesheny R, et al. Coding-Complete genome sequences of two SARS-CoV-2 isolates from Egypt. Microbiol Resour Announc. 2020;9(22):e00489-20.
   PubMed Web of Science ®Google Scholar
• GabAllah M, et al. Antiviral activity of water extracts of some medicinal and nutritive plants from the Apiaceae family. Novel Res Microbiol J. 2020;4(2):725–735.
   Google Scholar
• Kutkat O, Kandeil A, Moatasim Y, et al. In vitro and in vivo antiviral studies of new heteroannulated 1,2,3-Triazole glycosides targeting the neuraminidase of Influenza A viruses. Pharmaceuticals (Basel). 2022;15(3):351.
   PubMedGoogle Scholar
• Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol. 1938;27(3):493–497.
   Google Scholar
• Feoktistova M, Geserick P, Leverkus M. Crystal violet assay for determining viability of cultured cells. Cold Spring Harb Protoc. 2016;2016(4):pdb.prot087379.
   PubMedGoogle Scholar
• Mahmoud DB, Ismail WM, Moatasim Y, et al. Delineating a potent antiviral activity of Cuphea ignea extract loaded nano-formulation against SARS-CoV-2: in silico and in vitro studies. J Drug Deliv Sci Technol. 2021;66:102845.
   PubMed Web of Science ®Google Scholar
• Mostafa A, Kandeil A, A. M. M. Elshaier Y, et al. FDA-Approved drugs with potent in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2. Pharmaceuticals. 2020;13(12):443.
   Web of Science ®Google Scholar
• Seliem IA, Girgis AS, Moatasim Y, et al. New pyrazine conjugates: synthesis, computational studies, and antiviral properties against SARS-CoV-2. ChemMedChem. 2021;16(22):3418–3427.
   PubMed Web of Science ®Google Scholar
• Kandeil A, Mostafa A, Kutkat O, et al. Bioactive polyphenolic compounds showing strong antiviral activities against severe acute respiratory syndrome coronavirus 2. Pathogens (Basel, Switzerland). 2021;10(6):758.
   PubMed Web of Science ®Google Scholar
• Tobita K. Permanent canine kidney (MDCK) cells for isolation and plaque assay of Influenza B viruses. Med Microbiol Immunol. 1975;162(1):23–27.
   PubMed Web of Science ®Google Scholar
• Janson G, Zhang C, Prado MG, et al. PyMod 2.0: improvements in protein sequence-structure analysis and homology modeling within PyMOL. Bioinformatics. 2017;33(3):444–446.
   PubMed Web of Science ®Google Scholar
• Kuo Y-C, Lin L-C, Tsai W-J, et al. Samarangenin B from Limonium sinense suppresses herpes simplex virus type 1 replication in vero cells by regulation of viral macromolecular synthesis. Antimicrob Agents Chemother. 2002;46(9):2854–2864.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhan B, Yao X, et al. Antiviral activity of tannin from the pericarp of Punica granatum L. against genital herpes virus in vitro. Zhongguo Zhong Yao Za Zhi. 1995;20(9):556–558, 576.
   PubMedGoogle Scholar
• Schuhmacher A, Reichling J, Schnitzler P. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro. Phytomedicine. 2003;10(6-7):504–510.
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–461.
   PubMed Web of Science ®Google Scholar
• Wang N, Shi X, Jiang L, et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res. 2013;23(8):986–993.
   PubMed Web of Science ®Google Scholar
• Połeć K, Barnaś B, Kowalska M, et al. The influence of the essential oil extracted from HOPs on monolayers and bilayers imitating plant pathogen bacteria membranes. Colloids Surf B Biointerfaces. 2019;173:672–680.
   PubMed Web of Science ®Google Scholar
• Maietti A, Brighenti V, Bonetti G, et al. Metabolite profiling of flavonols and in vitro antioxidant activity of young shoots of wild Humulus lupulus L. (HOP). J Pharm Biomed Anal. 2017;142:28–34.
   PubMed Web of Science ®Google Scholar
• Ligor M, Stankevičius M, Wenda-Piesik A, et al. Comparative gas chromatographic–mass spectrometric evaluation of hop (Humulus lupulus L.) essential oils and extracts obtained using different sample preparation methods. Food Anal Methods. 2014;7(7):1433–1442.
   Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717–42713.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev. 1997;23(1–3):3–25.
   Web of Science ®Google Scholar
• Banerjee P, Eckert AO, Schrey AK, et al. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucl Acids Res. 2018;46(W1):W257–W263.
   PubMed Web of Science ®Google Scholar
• Guijarro-Real C, Plazas M. Potential in vitro inhibition of selected plant extracts against SARS-CoV-2 chymotripsin-like protease (3CL(Pro)) activity. Foods. 2021;10(7):1503.
   PubMed Web of Science ®Google Scholar
• Lautié E, Russo O, Ducrot P, et al. Unraveling plant natural chemical diversity for drug discovery purposes. Front Pharmacol. 2020;11:397.
   PubMed Web of Science ®Google Scholar
• Rates SM. Plants as source of drugs. Toxicon. 2001;39(5):603–613.
   PubMed Web of Science ®Google Scholar
• Veeresham C. Natural products derived from plants as a source of drugs. J Adv Pharm Technol Res. 2012;3(4):200–201.
   PubMedGoogle Scholar
• Chen L, Dou J, Su Z, et al. Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice. Antiviral Res. 2011;91(3):314–320.
   PubMed Web of Science ®Google Scholar
• Ibrahim AK, Youssef AI, Arafa AS, et al. Anti-H5N1 virus flavonoids from Capparis sinaica Veill. Nat Prod Res. 2013;27(22):2149–2153.
   PubMed Web of Science ®Google Scholar
• Lee J-H, Oh M, Seok J, et al. Antiviral effects of black raspberry (Rubus coreanus) seed and its gallic acid against influenza virus infection. Viruses. 2016;8(6):157.
   PubMed Web of Science ®Google Scholar
• V. K P, Rath SP, Abraham P. Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV. PLoS One. 2021;16(5):e0251913.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang Y, Wu L, et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020;181(4):894–904.e9.
   PubMed Web of Science ®Google Scholar
• Farouk A-E, Baig MH, Khan MI, et al. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: a viroinformatics study. Saudi J Biol Sci. 2021;28(6):3262–3269.
   PubMed Web of Science ®Google Scholar